Reduction of circulating endothelial cells in peripheral blood of ALS patients

PLoS One. 2010 May 12;5(5):e10614. doi: 10.1371/journal.pone.0010614.


Background: Amyotrophic Lateral Sclerosis (ALS) treatment is complicated by the various mechanisms underlying motor neuron degeneration. Recent studies showed that the blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) are compromised in an animal model of ALS due to endothelial cell degeneration. A later study demonstrated a loss of endothelium integrity in the spinal cords of ALS patients. Since circulating endothelial cells (CECs) in the peripheral blood are associated with endothelium damage, being detached dysfunctional endothelial cells, we hypothesized that CEC levels may reflect endothelium condition in ALS patients.

Methodology/principal findings: CEC levels were estimated in whole blood smears from ALS patients with moderate stage ((M)ALS), severe stage ((S)ALS), and healthy controls by CD146 expression using immunocytochemistry. A significant reduction of CECs was detected in (M)ALS and (S)ALS patients.

Conclusions/significance: CECs did not predict endothelium state in ALS patients; however, endothelial damage and/or impaired endothelium repair may occur in ALS leading to BBB/BSCB dysfunction. Reduced CECs in peripheral blood of ALS patients may indicate different mechanisms of endothelial damage and repair, rather than only detachment of dysfunctional endothelial cells. Although a potential mechanism of CEC reduction is discussed, establishing a reliable indicator of endothelial dysfunction/damage is important for evaluation of BBB/BSCB status in ALS patients during disease progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / blood*
  • Amyotrophic Lateral Sclerosis / pathology*
  • CD146 Antigen / metabolism
  • Case-Control Studies
  • Cell Movement*
  • Demography
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology*
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged


  • CD146 Antigen
  • MCAM protein, human